Meyersdale Medicaid reimbursements for COVID-19 services exceeded $1,970 in 2024

In Meyersdale, Medicaid reimbursements reached at least $1,970 in 2024 for medical services classified under HCPCS codes directly related to COVID-19, according to the U.S. Department of Health and Human Services Medicaid Provider Spending database. This marks a 181.4% rise from 2023, when providers filed $700 in claims against those specific codes.

Medicaid is a government health insurance program overseen by individual states and funded in partnership between federal and state governments. It covers low-income people and families, seniors, children, and those with disabilities, making it a significant component of the U.S. health system.

Since Medicaid payments are sourced from taxpayers, fluctuations in local claims reflect the distribution of public health care funding within a community.

This analysis identified COVID-19–related services through HCPCS codes labeled or classified as “COVID-19” or “coronavirus”-related in billing descriptions or reference data. The reported figures include only services explicitly marked as COVID-related and exclude pandemic-related care billed under broader or alternative medical codes.

For context, Pittsburgh recorded the highest amount of Medicaid payments for COVID-19-related services in Pennsylvania in 2024, with virus-related claims totaling $266,441.

Records indicate Dlp Conemaugh Meyersdale Medical Center LLC was the sole provider submitting Medicaid claims for COVID-19–related services in the city in 2024.

COVID-19–specific services made up a substantial portion of Medicaid spending growth in Meyersdale during the pandemic years.

Medicaid payments across all other claim categories rose by $89,593 from 2020 to 2024, an increase of 125.2%.

In the two years before the pandemic, Meyersdale’s average annual Medicaid payments were $12,718.

According to the Centers for Medicare & Medicaid Services, combined state and federal Medicaid expenditures totaled roughly $871.7 billion in fiscal 2023, representing about 18% of national health spending and rising significantly from around $613.5 billion in 2019, prior to the COVID-19 pandemic.

This increase reflects about 40% growth in just a few years, propelled mainly by greater enrollment and higher service use during and following the pandemic.

Recent federal budget measures under the Trump administration have included substantial proposals to scale back federal Medicaid funding and modify the program’s structure. The “One Big Beautiful Bill Act,” signed into law in 2025, is expected to reduce federal Medicaid outlays by more than $1 trillion over the next decade and brings policy changes such as work requirements and higher cost-sharing, which could decrease coverage and funding for some beneficiaries. These policies are likely to place increased cost burdens on states and restrain federal Medicaid growth while the program still serves tens of millions of Americans.

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

Data in this report was compiled from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The full dataset is available here.